While chemical and biochemical hypoglycemic agents, e.g., insulin, tolbutamide, phenformin, troglitazone, rosigitazone, and repaglinide, are the mainstay of treatment of diabetes and are effective in controlling hyperglycemia, they have harmful side-effects and fail to significantly alter the course of diabetic complications [2]. Here, INS is linked to diabetes mellitus.